skip to main | skip to sidebar
shearlings got plowed

Tuesday, February 5, 2013

The Completed Scheinberg Verdict Form


Here it is -- click to enlarge:



Posted by condor at 4:12 PM
Labels: $8 Million Boles II Verdict Merck Fosamax Bone Density Osteonecrosis Claims Femur and Jaw Jury Trial US Dist Ct NY Bellweather Case Boles June 25 2010 $285000 Scheinberg February 5 2013

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

FDA Help



A resource. . . .

Support Law Enforcement

Support Law Enforcement
Help Prevent Pharmaceutical Co. Fraud. . . .

IMPROVE-IT Vytorin/Zetia Results Will be Available NO SOONER THAN. . . .



So, just "sit tight" until then, okay?

New Merck's "Vietnam"?

New Merck's "Vietnam"?
An Inherited Mess. . . .

Only A Handful Of CEOs Clark & Hassan Documents?

Only A Handful Of CEOs Clark & Hassan Documents?
Out of 5.5 Million Pages?

More Discovery "Shenanigans"?

More Discovery "Shenanigans"?
In Vytorin Securities Litigation. . . .

"Deal-Goggles", Back ON?

"Deal-Goggles", Back ON?
That's Certainly Fred's M.O.

Wanna' Follow Along?

Follow ThreeDayCondor on Twitter

Quite A Come-Down?

Quite A Come-Down?
From $15B, to $12M. . . .

Another Of Hassan's Marbles?

Another Of Hassan's Marbles?
Not much of a stash, actually. . . .

Ex-CEO Hassan's Toys

Ex-CEO Hassan's Toys
Where He's Stashing the Marbles

Vioxx In the Supreme Court

Vioxx In the Supreme Court
What Was Justice Breyer Asking After?

Schering's "End-Run" -- on the Clayton Act?

Schering's "End-Run" -- on the Clayton Act?
Will it work? You decide. . . .

CEO Hassan's $1.2B Pharmacia Role. . .




. . .in the largest criminal
off-label case in U.S. history.

New Cancidas Questions

New Cancidas Questions
From FDA. . . .

A Place For S-P Alums




But not affiliated with this site. . . .

What Caused The "Bust-Up"?

What Caused The "Bust-Up"?
Mismanaged Disclosure of ENHANCE Results. . . .

Of Direct Marketing Miscues

Of Direct Marketing Miscues
And overwrought protests. . . .

Fosamax -- A Few Notes. . . .

Fosamax -- A Few Notes. . . .
Just Random Observations. . . .

Misleading Press Event: July 2008

Misleading Press Event: July 2008
Of (Falsely) "Forced Disclosures". . . .

Non-GAAP EPS Figures:

Non-GAAP EPS Figures:
"There Be UNICORNS -- In Yonder Forest!"

Even Pfizer Is "Finding Unicorns". . . .

Even Pfizer Is "Finding Unicorns". . . .
More "Adjusted" EPS Follies!

Hassan and Cox, Part Deux?

Hassan and Cox, Part Deux?
From 2000, at Pharmacia. . . .

DOCTOR Stephen Colbert!

DOCTOR Stephen Colbert!
. . . .on Medicine Over-use?

The CafePharma Posts = "Scienter"?

The CafePharma Posts = "Scienter"?
Judge Cavanaugh's Opinion, Explained. . . .

A Truth-Enhanced Ad!



From the Nice People
at Condor-TV!

In Enhance. . . .

In Enhance. . . .
"Blinding" did NOT matter.

Vytorin: SEAS, and Cancer Incidence Rates

Vytorin: SEAS, and Cancer Incidence Rates
A Theory Involving Plant Sterols. . . .

What is Sugammadex Worth?

What is Sugammadex Worth?
After FDA sez it's "Non-Approvable"

More FDA Resources. . .

Blog Archive

  • May (43)
  • April (59)
  • March (32)
  • February (29)
  • January (30)
  • December (7)
  • November (3)
  • October (9)
  • September (6)
  • August (4)
  • July (20)
  • June (17)
  • May (12)
  • April (14)
  • March (18)
  • February (29)
  • January (25)
  • December (16)
  • November (37)
  • October (24)
  • September (25)
  • August (13)
  • July (9)
  • June (10)
  • May (21)
  • April (34)
  • March (51)
  • February (28)
  • January (49)
  • December (71)
  • November (92)
  • October (81)
  • September (70)
  • August (63)
  • July (59)
  • June (62)
  • May (54)
  • April (58)
  • March (78)
  • February (46)
  • January (58)
  • December (66)
  • November (75)
  • October (79)
  • September (82)
  • August (86)
  • July (63)
  • June (61)
  • May (50)
  • April (40)
  • March (29)
  • February (22)
  • January (34)
  • December (35)
  • November (38)
  • October (40)
  • September (61)
  • August (42)
  • July (42)
  • June (34)
  • May (52)
  • April (56)
  • January (10)

Congress Investigates ENHANCE. . . .



Some thoughts. . . .

Senator Grassley's Concern



Was the ENHANCE data actually "blinded"?

stats

FDA Drug Facts



Another resource page. . . .

CEO Fred Hassan



"Breaking the Trust", on those days. . . .

The Condor. . . .



What a Great Flick!
Who is he?

Legal Stuff; Creative Commons Statement 2008

Nothing written, appearing, or linked to, on this site is intended to be individual legal, or investment, advice. Consult a financial or legal adviser before making any trade, or any other decision, based anything you read, or see, on this website. This website treats all U.S. viewers' vistor-paths -- and visits -- as public data. If you are from Europe, understand that this site can see -- but will not disclose to the public -- your visitor-path, in compliance with applicable E.U. directives. All material on this website is derived from public documents, and/or edited, modified, and derived from public domain sources, or in some cases, originally-created by the author(s) of this site. Any use of any proprietary image, document or other data is genuinely-intended by the author(s) to fall under the common-law "fair use" doctrine, as criticism of, and commentary on, matters of substantial public concern -- among them, the for-profit health care system in the Americas. If any person wishes to dispute this assertion of "fair use", please leave a comment in any of the comment-boxes, specifically-identifying the challenged material, and the basis for the challenge, on this site. The Site Administrator(s) will promptly consider the claim. In the same comment-box, the Site Administrator(s) will indicate the site's position on any such claim. This site is not-for-profit. Share, and share-a-like, licenses granted in, and to, all content. Copy-left 2008 though 2013.

blogger.com is great!